Xeris Biopharma
ApprovedXeris Pharmaceuticals (XERS) improves patient lives by developing and commercializing innovative, ready-to-use therapeutic medicine.
Founded
2005
Focus
Drug DeliverySmall Molecules
About
Xeris Pharmaceuticals (XERS) improves patient lives by developing and commercializing innovative, ready-to-use therapeutic medicine.
Funding History
5Total raised: $250M
PIPE$50MUndisclosedDec 15, 2020
IPO$75MUndisclosedAug 15, 2018
Series C$60MUndisclosedMay 15, 2018
Series B$45MUndisclosedMar 15, 2017
Company Info
TypePrivate
Founded2005
LocationChicago, United States
StageApproved
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile